Literature DB >> 33987118

Palatoschisis, Schizophrenia and Hypocalcaemia: Phenotypic Expression of 22q11.2 Deletion Syndrome (DiGeorge Syndrome) in an Adult.

Melissa Elise van der Meijs1, Dave Henri Schweitzer1, Henk Boom1.   

Abstract

22q11.2 deletion syndrome typically presents with congenital cardiac anomalies, immunodeficiencies and hypoparathyroidism. However, clinical findings vary greatly. We present the case of a 56-year-old man, with a history of cleft palate and schizophrenia, who was newly diagnosed with 22q11.2 deletion syndrome during an episode of hypocalcaemia. The syndrome is caused by developmental abnormalities of the embryonic pharyngeal arch system. Treatment of hypocalcaemia with oral calcium and vitamin D is usually sufficient. LEARNING POINTS: 22q11.2 deletion syndrome typically presents with congenital cardiac anomalies, immunodeficiencies and hypoparathyroidism.The syndrome has a variable phenotypic expression and can therefore remain unrecognised in adult patients with mild symptoms.22q11.2 deletion syndrome should be borne in mind, particularly as regards adult psychiatric patients. © EFIM 2021.

Entities:  

Keywords:  22q11.2 deletion syndrome; DiGeorge syndrome; hypocalcaemia; hypoparathyroidism

Year:  2021        PMID: 33987118      PMCID: PMC8112094          DOI: 10.12890/2021_002411

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  8 in total

1.  Practical guidelines for managing patients with 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Donna M McDonald-McGinn; Koen Devriendt; Maria Cristina Digilio; Paula Goldenberg; Alex Habel; Bruno Marino; Solveig Oskarsdottir; Nicole Philip; Kathleen Sullivan; Ann Swillen; Jacob Vorstman
Journal:  J Pediatr       Date:  2011-05-12       Impact factor: 4.406

Review 2.  Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

Review 3.  Phenotype of adults with the 22q11 deletion syndrome: A review.

Authors:  E Cohen; E W Chow; R Weksberg; A S Bassett
Journal:  Am J Med Genet       Date:  1999-10-08

Review 4.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

5.  Role of TBX1 in human del22q11.2 syndrome.

Authors:  Hisato Yagi; Yoshiyuki Furutani; Hiromichi Hamada; Takashi Sasaki; Shuichi Asakawa; Shinsei Minoshima; Fukiko Ichida; Kunitaka Joo; Misa Kimura; Shin-ichiro Imamura; Naoyuki Kamatani; Kazuo Momma; Atsuyoshi Takao; Makoto Nakazawa; Nobuyoshi Shimizu; Rumiko Matsuoka
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321

6.  Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism.

Authors:  Patrizia Matarazzo; Gerdi Tuli; Ludovica Fiore; Alessandro Mussa; Francesca Feyles; Valentina Peiretti; Roberto Lala
Journal:  J Pediatr Endocrinol Metab       Date:  2014-01       Impact factor: 1.634

Review 7.  Endocrine aspects of the 22q11.2 deletion syndrome.

Authors:  S A Weinzimer
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

8.  DiGeorge syndrome : Relevance of psychiatric symptoms in undiagnosed adult patients.

Authors:  Christoph Kraus; Thomas Vanicek; Ana Weidenauer; Tav Khanaqa; Mara Stamenkovic; Rupert Lanzenberger; Matthäus Willeit; Siegfried Kasper
Journal:  Wien Klin Wochenschr       Date:  2018-04-18       Impact factor: 1.704

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.